# A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects

> **NCT02576119** · PHASE1 · TERMINATED · sponsor: **ViiV Healthcare** · enrollment: 315 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus

## Interventions

- **DRUG:** BMS-955176, Placebo (Part 1)
- **DRUG:** BMS-955176, Moxifloxacin, Placebo (Part 2)

## Key facts

- **NCT ID:** NCT02576119
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10-19
- **Primary completion:** 2016-02-26
- **Final completion:** 2016-10-14
- **Target enrollment:** 315 (ACTUAL)
- **Why stopped:** This study was terminated early due to neuropsychiatric serious adverse events reported by 2 participants.
- **Last updated:** 2017-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576119, "A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02576119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*